These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35582313)

  • 1. Level I PD-MCI Using Global Cognitive Tests and the Risk for Parkinson's Disease Dementia.
    Boel JA; de Bie RMA; Schmand BA; Dalrymple-Alford JC; Marras C; Adler CH; Goldman JG; Tröster AI; Burn DJ; Litvan I; Geurtsen GJ;
    Mov Disord Clin Pract; 2022 May; 9(4):479-483. PubMed ID: 35582313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mild cognitive impairment in Parkinson's disease and its progression onto dementia: a 16-year outcome evaluation of the Denbighshire cohort.
    Hobson P; Meara J
    Int J Geriatr Psychiatry; 2015 Oct; 30(10):1048-55. PubMed ID: 25676160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Montreal Cognitive Assessment for the screening and prediction of cognitive decline in early Parkinson's disease.
    Kandiah N; Zhang A; Cenina AR; Au WL; Nadkarni N; Tan LC
    Parkinsonism Relat Disord; 2014 Nov; 20(11):1145-8. PubMed ID: 25176439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of cognitive progression in Parkinson's disease using three cognitive screening measures.
    Kim HM; Nazor C; Zabetian CP; Quinn JF; Chung KA; Hiller AL; Hu SC; Leverenz JB; Montine TJ; Edwards KL; Cholerton B
    Clin Park Relat Disord; 2019; 1():91-97. PubMed ID: 32368733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A New Instrument Combines Cognitive and Social Functioning Items for Detecting Mild Cognitive Impairment and Dementia in Parkinson's Disease.
    Yu YW; Tan CH; Su HC; Chien CY; Sung PS; Lin TY; Lee TL; Yu RL
    Front Aging Neurosci; 2022; 14():913958. PubMed ID: 35783135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of Mild Cognitive Impairment and Dementia in Parkinson's Disease: The Parkinson's Disease Cognitive Impairment Study.
    Nicoletti A; Luca A; Baschi R; Cicero CE; Mostile G; Davì M; Pilati L; Restivo V; Zappia M; Monastero R
    Front Aging Neurosci; 2019; 11():21. PubMed ID: 30800065
    [No Abstract]   [Full Text] [Related]  

  • 7. Apolipoprotein Eε4: A Biomarker for Executive Dysfunction among Parkinson's Disease Patients with Mild Cognitive Impairment.
    Samat NA; Abdul Murad NA; Mohamad K; Abdul Razak MR; Mohamed Ibrahim N
    Front Neurosci; 2017; 11():712. PubMed ID: 29326545
    [No Abstract]   [Full Text] [Related]  

  • 8. Validity and reliability of the Persian version of the Montreal Cognitive Assessment (MoCA-P) scale among subjects with Parkinson's disease.
    Badrkhahan SZ; Sikaroodi H; Sharifi F; Kouti L; Noroozian M
    Appl Neuropsychol Adult; 2020; 27(5):431-439. PubMed ID: 30821505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease.
    Hoops S; Nazem S; Siderowf AD; Duda JE; Xie SX; Stern MB; Weintraub D
    Neurology; 2009 Nov; 73(21):1738-45. PubMed ID: 19933974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal MoCA and normal range MMSE scores in Parkinson disease without dementia: cognitive and neurochemical correlates.
    Chou KL; Lenhart A; Koeppe RA; Bohnen NI
    Parkinsonism Relat Disord; 2014 Oct; 20(10):1076-80. PubMed ID: 25085750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosing mild cognitive impairment in Parkinson's disease: which tests perform best in the Italian population?
    Federico A; Trentin M; Zanette G; Mapelli D; Picelli A; Smania N; Tinazzi M; Tamburin S
    Neurol Sci; 2017 Aug; 38(8):1461-1468. PubMed ID: 28550344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The MMSE and MoCA for Screening Cognitive Impairment in Less Educated Patients with Parkinson's Disease.
    Kim JI; Sunwoo MK; Sohn YH; Lee PH; Hong JY
    J Mov Disord; 2016 Sep; 9(3):152-9. PubMed ID: 27667187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Single-institution Study on Predictors of Short-term Progression from Mild Cognitive Impairment in Parkinson's Disease to Parkinson's Disease with Dementia.
    Tajiri Y; Wada-Isoe K; Tanaka K; Adachi T; Hanajima R; Nakashima K
    Yonago Acta Med; 2020 Feb; 63(1):28-33. PubMed ID: 32158330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fist-Edge-Palm (FEP) test has a high sensitivity in differentiating dementia from normal cognition in Parkinson's disease.
    Liu Y; Qiu MY; Zhang YL; Zhang XJ; Truong D; Tan EK; Wu YC
    J Neurol Sci; 2021 Oct; 429():118060. PubMed ID: 34479167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for Mild Cognitive Impairment in Parkinson's Disease: Comparison of the Italian Versions of Three Neuropsychological Tests.
    Federico A; Maier A; Vianello G; Mapelli D; Trentin M; Zanette G; Picelli A; Gandolfi M; Tamburin S
    Parkinsons Dis; 2015; 2015():681976. PubMed ID: 26634171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Which Neuropsychological Tests? Predicting Cognitive Decline and Dementia in Parkinson's Disease in the ICICLE-PD Cohort.
    Lawson RA; Williams-Gray CH; Camacho M; Duncan GW; Khoo TK; Breen DP; Barker RA; Rochester L; Burn DJ; Yarnall AJ;
    J Parkinsons Dis; 2021; 11(3):1297-1308. PubMed ID: 34024781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the Random Forest Algorithm Suitable for Predicting Parkinson's Disease with Mild Cognitive Impairment out of Parkinson's Disease with Normal Cognition?
    Byeon H
    Int J Environ Res Public Health; 2020 Apr; 17(7):. PubMed ID: 32290134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining optimal cutoff scores for cognitive impairment using Movement Disorder Society Task Force criteria for mild cognitive impairment in Parkinson's disease.
    Goldman JG; Holden S; Bernard B; Ouyang B; Goetz CG; Stebbins GT
    Mov Disord; 2013 Dec; 28(14):1972-9. PubMed ID: 24123267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-Analysis of Cognition in Parkinson's Disease Mild Cognitive Impairment and Dementia Progression.
    Wallace ER; Segerstrom SC; van Horne CG; Schmitt FA; Koehl LM
    Neuropsychol Rev; 2022 Mar; 32(1):149-160. PubMed ID: 33860906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mild cognitive impairment in Parkinson's disease: Diagnosis and progression to dementia.
    Galtier I; Nieto A; Lorenzo JN; Barroso J
    J Clin Exp Neuropsychol; 2016; 38(1):40-50. PubMed ID: 26602176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.